ExchangeDEX+

Buy Crypto Markets Spot FuturesSILVER Earn Event Centre

NeuroOne Medical Technologies announces a virtual investor webinar on March 12, 2026, to discuss corporate updates and FDA-cleared neurological treatment technologiesNeuroOne Medical Technologies announces a virtual investor webinar on March 12, 2026, to discuss corporate updates and FDA-cleared neurological treatment technologies

NeuroOne Announces Virtual Investor Webinar to Discuss Growth and Technology Updates

Author: Citybuzz

Source: Citybuzz

2026/02/26 21:28

2 min read

VIRTUAL$0.6681-5.60%

NeuroOne Medical Technologies Corporation, trading on Nasdaq as NMTC, announced it will hold a virtual investor webinar on Thursday, March 12, 2026, at 11:30 a.m. Eastern Time. The company, which focuses on transforming surgical diagnosis and treatment for neurological disorders, will have management provide a corporate update, discuss growth plans, and offer updates on its platform technologies, applications, and commercialization efforts. A question-and-answer session will follow the presentation.

The implications of this announcement are significant for investors and the medical community, as NeuroOne’s technologies aim to improve surgical care for neurological conditions. The company markets a minimally invasive electrode technology platform with four FDA-cleared product families: Evo Cortical Electrodes, Evo sEEG Electrodes, OneRF Ablation System for the brain, and OneRF Trigeminal Nerve Ablation System. These solutions are designed to reduce hospitalizations and surgical procedures, lower costs, and enhance patient outcomes by combining diagnostic and therapeutic functions. For more information on the company’s offerings, visit nmtc1.com.

During the webinar, participants can join via webcast at https://www.webcaster4.com/Webcast/Page/2914/53635 or by dialing in with the provided numbers. The event underscores NeuroOne’s ongoing efforts in research and development, including programs for drug delivery and spinal cord stimulation, which could further advance treatment options for patients. A replay of the call will be available through Thursday, March 26, 2026, accessible via the same webcast link or by phone, using replay passcode 53635. This update is crucial as it highlights the company’s progress in a field where innovative medical technologies can lead to better health outcomes and economic efficiencies in healthcare.

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is NeuroOne Announces Virtual Investor Webinar to Discuss Growth and Technology Updates.

The post NeuroOne Announces Virtual Investor Webinar to Discuss Growth and Technology Updates appeared first on citybuzz.

Market Opportunity

Virtuals Protocol Price(VIRTUAL)

$0.6681

$0.6681$0.6681

-2.73%

USD

Virtuals Protocol (VIRTUAL) Live Price Chart

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.